Skip to content
Search

Latest Stories

Community pharmacy shouldn’t rely solely on CPCF income

Community pharmacy must now focus on matters in their direct control as part of a robust business plan.

Community pharmacy must now focus on matters in their direct control

The new Community Pharmacy Contractual Framework is a step in the right direction - Victoria Steele

Victoria Steele

Over the coming days much will be/is being written about the Community Pharmacy Contractual Framework and the Independent Economic Review. Emotions are understandably high this week and as everyone has already said, the devil is in the detail.

I must admit to being puzzled by the behaviours that I’m witnessing, and energy being expended at Community Pharmacy England’s door rather than that of government. Only those in the room whilst negotiating will know what information they were dealing with and as is always the case in these situations, they (CPE) are undoubtedly in an unenviable position where nothing they could do would have been right (or certainly not enough).


The truth is, with or without the economic review, everyone knows the dire situation community pharmacy has found itself in over the years and the (at times) appalling way it has been treated, undervalued or forgotten.

This framework is a step in the right direction and recognition of the historical situation. However, whatever the figure had been, this was never going to be a magic bullet or the number everyone wanted.

In my opinion, relying solely on income from CPCF now or in recent times has not been a sensible place to operate and I have had this demonstrated to me beautifully over the last few months whilst working alongside innovative, enthusiastic small-medium sized organisations supporting them as they develop and grow their ambitious plans.

They have identified gaps in the market, (or their locality) and they are growing, developing and, dare I say, thriving. Keen and eager to demonstrate effective leadership and engage the right individuals in their organisations whilst developing marketing plans and ensuring robust risk management, clinical and information governance plans are in place as they grow. I believe digital and hardware technology definitely has a place here but understand the investment needed and how that may feel a way off for many organisations.

I appreciate that this may be an unpopular opinion, but I truly believe innovation and growth is the answer as nobody’s business should be reliant on one source of income in any walk of life.

That said, I am disappointed that immediate cash flow issues haven’t been addressed in this deal as I think that would have helped in the short term.

However, I am pleased to see such a reduction in red tape and bureaucracy, something that is often overlooked and will significantly reduce the over-arching burden. I have always felt that reducing the non-productive bureaucracy is a helpful and adaptable tool that should be utilised more often.

I do believe that this framework acknowledges how valued and well-loved pharmacy is, I have watched in admiration over the last few months at my peers across various organisations as they have worked tirelessly to spread the word and to ensure that pharmacy remains front and centre on all media outlets throughout this period. They should be congratulated and thanked for their efforts.

I’m conscious that I may be sounding too optimistic, but I do think I am being realistic. This is a starting point and I feel government has listened, if not able to act fully at this stage and a long way to go.

Community pharmacy still holds that unique and trusted position in community but must now focus on matters in their direct control – their people, their premises, their operation, their relationships, their services and their marketing as part of a robust business plan.

I know contractors will be crunching their numbers and reviewing their business plans. CPE will be working out their position and business case for the start of August’s negotiations on 2026/27 funding. Much to be done!

Victoria Steele is the Founder and Director of Steelier Ltd and the ex -superintendent of LloydsPharmacy

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
A Royal College of Pharmacy

A Royal College of Pharmacy will aim to have a united voice

Pic credit: iStock

A Royal College of Pharmacy:  The what, the why and the how

By Mike Holden,

The what

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less